COVID took the world by stunned surprise – but, to quote an old Who song, we won't be fooled again.
That's thanks to accelerated genome sequencing technologies, expanded laboratory capabilities, and interacting infrastructure on a global level. These factors are converging to enable both identification of novel infectious diseases as well as microbial resistance, before these threats can impact public health, write a team from the European Society for Clinical Microbiology and Infectious Diseases in Frontiers in Science.
To continue reading, go to DNA Science, where this post first appeared.